Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1953 USD | -4.96% |
|
-11.63% | -79.76% |
04/06 | Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting | CI |
08/05 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.25Cr | - | - | - | - | - | |
12TCr | ||||||
11TCr | ||||||
2.26TCr | - | |||||
2.08TCr | - | |||||
1.63TCr | - |
- Stock Market
- Equities
- APLM Stock
- Charts Apollomics, Inc.
- Sector Chart